116 related articles for article (PubMed ID: 29901560)
1. Health Status and Health-related Quality of Life Measurement in Pediatric Cancer Clinical Trials: An Examination of the DFCI 00-01 Acute Lymphoblastic Leukemia Protocol.
Rae C; Furlong W; Feeny D; Couchman R; Silverman L; Sallan S; Laverdiere C; Clavell L; Michon B; Kelly K; Larsen E; Pullenayegum E; Athale U; Barr R
J Pediatr Hematol Oncol; 2018 Nov; 40(8):580-587. PubMed ID: 29901560
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of treatment for acute lymphoblastic leukaemia in childhood.
Rae C; Furlong W; Jankovic M; Moghrabi A; Naqvi A; Sala A; Samson Y; DePauw S; Feeny D; Barr R
Eur J Cancer Care (Engl); 2014 Nov; 23(6):779-85. PubMed ID: 24393150
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life among children with acute lymphoblastic leukemia.
Furlong W; Rae C; Feeny D; Gelber RD; Laverdiere C; Michon B; Silverman L; Sallan S; Barr R
Pediatr Blood Cancer; 2012 Oct; 59(4):717-24. PubMed ID: 22294502
[TBL] [Abstract][Full Text] [Related]
4. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
5. Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada.
Gupta S; Sutradhar R; Li Q; Athale U; Bassal M; Breakey V; Gibson PJ; Patel S; Silva M; Zabih V; Pechlivanoglou P; Pole JD; Mittmann N
Eur J Cancer; 2021 Jul; 151():126-135. PubMed ID: 33979728
[TBL] [Abstract][Full Text] [Related]
6. Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
Desai SJ; Barr RD; Andrew M; deVeber LL; Pai MK
CMAJ; 1989 Oct; 141(7):693-7. PubMed ID: 2790605
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life (HRQL) in all-patients treated with chemotherapy only: a report from the late effects surveillance system in Germany.
Peeters J; Meitert J; Paulides M; Wiener A; Beck JD; Calaminus G; Langer T
Klin Padiatr; 2009; 221(3):156-61. PubMed ID: 19437363
[TBL] [Abstract][Full Text] [Related]
8. Comparative results of two intensive treatment programs for childhood acute lymphoblastic leukemia: The Berlin-Frankfurt-Münster and Dana-Farber Cancer Institute protocols.
Niemeyer CM; Reiter A; Riehm H; Donnelly M; Gelber RD; Sallan SE
Ann Oncol; 1991; 2(10):745-9. PubMed ID: 1801880
[TBL] [Abstract][Full Text] [Related]
9. Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia.
Kreissman SG; Gelber RD; Cohen HJ; Clavell LA; Leavitt P; Sallan SE
Cancer; 1992 Oct; 70(8):2208-13. PubMed ID: 1394053
[TBL] [Abstract][Full Text] [Related]
10. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
Hurwitz CA; Silverman LB; Schorin MA; Clavell LA; Dalton VK; Glick KM; Gelber RD; Sallan SE
Cancer; 2000 Apr; 88(8):1964-9. PubMed ID: 10760775
[TBL] [Abstract][Full Text] [Related]
11. Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.
Athale UH; Puligandla M; Stevenson KE; Asselin B; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Sulis ML; Welch JJG; Harris MH; Neuberg DS; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2018 Oct; 65(10):e27256. PubMed ID: 29878490
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in long-term survivors of acute lymphoblastic leukemia in childhood and adolescence.
Nayiager T; Anderson L; Cranston A; Athale U; Barr RD
Qual Life Res; 2017 May; 26(5):1371-1377. PubMed ID: 27885548
[TBL] [Abstract][Full Text] [Related]
13. Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995).
Silverman LB; Declerck L; Gelber RD; Dalton VK; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin MA; Lipton JM; Cohen HJ; Sallan SE
Leukemia; 2000 Dec; 14(12):2247-56. PubMed ID: 11187916
[TBL] [Abstract][Full Text] [Related]
14. Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.
Athale UH; Siciliano SA; Crowther M; Barr RD; Chan AK
Br J Haematol; 2005 Jun; 129(6):803-10. PubMed ID: 15953008
[TBL] [Abstract][Full Text] [Related]
15. [Acute lymphoblastic leukemia in childhood. A 10-year experience with the DFCI 81-01 protocol].
de Lacerda AF; Chagas M; Neto A; Vieira E; Ribeiro MJ; Pereira F; Ambrósio A; Sousinha M
Acta Med Port; 1999; 12(7-11):287-92. PubMed ID: 10707467
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life of children on treatment for acute lymphoblastic leukemia: A systematic review.
Fardell JE; Vetsch J; Trahair T; Mateos MK; Grootenhuis MA; Touyz LM; Marshall GM; Wakefield CE
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28266135
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of rituximab in addition to standard of care chemotherapy for adult patients with acute lymphoblastic leukemia.
Nam J; Milenkovski R; Yunger S; Geirnaert M; Paulson K; Seftel M
J Med Econ; 2018 Jan; 21(1):47-59. PubMed ID: 28837377
[TBL] [Abstract][Full Text] [Related]
18. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.
Barry E; DeAngelo DJ; Neuberg D; Stevenson K; Loh ML; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin M; Cohen HJ; Sallan SE; Silverman LB
J Clin Oncol; 2007 Mar; 25(7):813-9. PubMed ID: 17327603
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma has a global impact on health related quality of life: Findings from an international cohort.
de Medeiros CB; Moxon-Emre I; Scantlebury N; Malkin D; Ramaswamy V; Decker A; Law N; Kumabe T; Leonard J; Rubin J; Jung S; Kim SK; Gupta N; Weiss W; Faria CC; Vibhakar R; Lafay-Cousin L; Chan J; Kros JM; Janzen L; Taylor MD; Bouffet E; Mabbott DJ
Cancer Med; 2020 Jan; 9(2):447-459. PubMed ID: 31755223
[TBL] [Abstract][Full Text] [Related]
20. Improved survival using an intensive, pediatric-based chemotherapy regimen in adults with T-cell acute lymphoblastic leukemia.
Al-Khabori M; Minden MD; Yee KW; Gupta V; Schimmer AD; Schuh AC; Xu W; Brandwein JM
Leuk Lymphoma; 2010 Jan; 51(1):61-5. PubMed ID: 20017600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
